Ashok Balasubramanyam, MD, Chair
Dr. Balasubramanyam, a board-certified internist and endocrinologist, is Professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, Vice President for Academic Integration and Senior Associate Dean for Academic Affairs at Baylor College of Medicine, Houston, TX. His academic career involves basic and translational research in diabetes and metabolic diseases, education (including service as past director of the endocrine fellowship program and current director of Baylor’s Clinical Scientist Training Program), and clinical practice as an internist and endocrine consultant.
Currently, Dr. Balasubramanyam serves as a member of the ABIM Council and the Chair of the Endocrinology, Disease, and Metabolism Board of the American Board of Internal Medicine. He is a past President of the Association of Program Directors in Endocrinology and Metabolism.
Dr. Balasubramanyam earned his undergraduate degree at Yale University and his medical degree at St. John’s Medical College, Bangalore, India. He completed residency training and was Chief Resident at Baylor College of Medicine, and completed clinical and research fellowship training in endocrinology at the Massachusetts General Hospital, Boston.
As of August 2019, Dr. Balasubramanyam reported the following external relationship:
Work as an author or editor for the following company, with compensation as listed below:
- UpToDate, receiving compensation for authorship.
Dr. Balasubramanyam serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Harris County Medical Society, Board Member, without compensation.
Shehzad Basaria, MD
Dr. Basaria is a reproductive endocrinologist and the Associate Director of the Section of Men’s Health, Aging and Metabolism at the Brigham and Women’s Hospital, Harvard Medical School. He is board certified in Endocrinology, Diabetes, and Metabolism.
Dr. Basaria is a clinical investigator in the field of male reproductive endocrinology. His research interests include assessing the efficacy of testosterone therapy in cancer-related fatigue, pain perception and aging. His research interests also include assessing the cardiometabolic consequences of androgen deprivation therapy in men with prostate cancer.
Dr. Basaria also provides clinical care to patients with a variety of male reproductive disorders, including patients with cancer and those with opioid-induced hypogonadism. Additionally, he is a mentor to junior faculty and endocrine fellows pursuing their careers in reproductive endocrinology.
Dr. Basaria is a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Exam Writing Committee. He is the Associate Editor of the Journal of Gerontology Medical Sciences, and has previously served on the editorial board of the Journal of Clinical Endocrinology and Metabolism. Previously, Dr. Basaria led the section on Male Reproduction on the Self-Assessment Committee of the Endocrine Society and was also involved in developing the Endocrine Society's Male Androgen Deficiency Performance Improvement Module, which practicing endocrinologists utilize towards their Maintenance of Certification. Dr. Basaria serves as a member of the National Institute of Child Health and Development’s Special Emphasis Panel on Male Contraception, and on the National Institute on Aging’s Panel on Aging and Mobility.
Dr. Basaria received his medical degree from The Aga Khan University Medical College in Karachi, Pakistan. He completed house staff training at The University of Texas Health Science Center at Houston and his endocrine fellowship at The Johns Hopkins University School of Medicine.
As of August 2020, Dr. Basaria reported no external relationships.
Mr. Bloom, a thyroid cancer survivor, is co-founder and Executive Director of ThyCa: Thyroid Cancer Survivors’ Association, Inc., where he directs the overall organization, including: operational, technological, and financial management, and maintains collaborations with numerous professional, patient, and community organizations. He works closely with the ThyCa volunteer Board of Directors and committee coordinators. Mr. Bloom leads committee development and directs fundraising. He also develops the program for the Annual International Thyroid Cancer Survivors' Conference and recruits all professional speakers. Mr. Bloom is a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Board.
Previously, Mr. Bloom served as an Applications Engineer for Eclipsys Corporation where he designed and implemented workflow streamlining applications for large health care organizations. He also developed custom and standard reports, and prepared teaching materials and trained clients in the use of Eclipsys’ database structure and reporting system.
Mr. Bloom also served as Controller and Director of Operations at Intelus where he was responsible for all financial, human resources, and administrative responsibilities. He was responsible for all financial activity and financial reporting to management, venture capital investors, and the Board of Directors. Additionally, he secured and managed employee benefits, facility space requirements, office insurance and security.
Mr. Bloom has a bachelor's degree in accounting from the University of Vermont.
As of August 2020, Mr. Bloom reported the following external relationships:
Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:
- Blueprint Medicines, Advisory Board Member.
Mr. Bloom serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- ThyCa: Thyroid Cancer Survivors' Association, Inc., Executive Director and Board Member, receiving compensation and reimbursement for travel expenses.
Whitney Goldner, MD
Dr. Goldner is an Endocrinologist and Professor of Medicine, Division of Diabetes, Endocrinology and Metabolism at the University of Nebraska Medical Center/Nebraska Medicine. Dr. Goldner is board certified in both Internal Medicine and Endocrinology, Diabetes and Metabolism. She has a clinical focus on thyroid disorders, thyroid nodules, and thyroid cancer and is the Director of the Thyroid and Endocrine Tumor program at the Fred and Pamela Buffett Cancer Center at Nebraska Medicine.
She previously served as the Endocrinology Fellowship program director and was also on the Association of Program Directors in Diabetes, Endocrinology, and Metabolism (APDEM) council. She has also served on the University of Nebraska Medical Center GME and GME Executive Board. Dr. Goldner continues to be a member of the Endocrinology Fellowship Clinical Competency Committee and the program evaluation committee and she is one of the core faculty for both the Endocrinology fellowship and the Internal Medicine Residency at the University of Nebraska Medical Center.
Dr. Goldner is actively involved in both the Endocrine Society and the American Thyroid Association. She is currently on the board of the Endocrine Society and have served on and/or chaired multiple educational committees in the past including: the scientific education committee (SCIED), clinical evaluation and education committee (CEEC), and the clinical endocrinology update (CEU). She is currently a co-Chair of the spring meeting for the ATA, and have served as the chair of the trainee and career advancement committee and president of Women in Thyroidology. She also serves on the NCCN Neuroendocrine and Adrenal Tumor and Thyroid Cancer Guidelines committees.
As of August 2020, Dr. Goldner reported the following external relationships:
Funding for clinical trial expenses, salary support and staff, paid to University of Nebraska Medical center, from the following company:
- Roche, serving at the site Principal Investigator.
Dr. Goldner serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- The Endocrine Society, Board Member, receiving reimbursement for travel expenses.
- American Thyroid Association, Committee Chair, without compensation.
Ann Marie Hasse, RN, BSN, CDE
Ms. Hasse has been a nurse for 31 years. She has been a Certified Diabetes and Educational Specialist (CDCES) for 20 years. As a CDCES, she has worked with people with diabetes in the inpatient , outpatient, and community settings. Since 2018, she is the Inpatient Diabetes Educator at Long Island Jewish Medical Center. She has assisted several hospitals within Northwell Health to achieve certification for Inpatient Diabetes Management from The Joint Commission.
Ms. Hasse is a member of the Association of Diabetes Care and Education Specialist (ADCES). As a CDCES, her experience has included trying to improve transition of care within Northwell Health and within ACDES, Community of Interest groups. Ms. Hasse is also the co-Chair of the Diabetes Best Practice Work Group in Northwell Health, which works on creating policies, protocols, and order sets to improve the care and safety of those living with diabetes in the hospital. She is an abstract reviewer for The Journal of Patient Experience. In 2018, she also became a board certified Nurse Coach and board certified Holistic Nurse. In 2021, she became a member on the American Board of Internal Medicine for Endocrinology.
Ms. Hasse received her bachelor's degree from Molloy College and her master's degree in nursing education from Regis University.
As of November 2020, Dr. Haase reported no ongoing external relationships.
Jonathan D. Leffert, MD
Dr. Leffert is a board-certified clinical endocrinologist and Managing Partner of North Texas Endocrine Center in Dallas, Texas. He has been in private single specialty group or solo practice for the last 29 years, where his passion for excellent patient care drives him daily in his clinical and organizational activities.
Dr. Leffert has been active in organizational medicine since 2000, serving on the board of his county medical society, state medical society Political Action Committee, and is past-President of the American Association of Clinical Endocrinologists (AACE). In addition, he is currently the Delegate to the American Medical Association (AMA) for AACE. At the AMA House of Delegates Meeting in 2013, Dr. Leffert led a coalition that resulted in the designation of obesity as a disease. He is currently a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Board.
Dr. Leffert received a degree in biology from Brown University and his medical degree from the University of Minnesota.
He completed his internship and residency in internal medicine at University of Texas (UT) Southwestern/Parkland Memorial Hospital. Dr. Leffert began his research fellowship by studying genes that regulate carbohydrate metabolism in the Touchstone Diabetes Center and completed his clinical fellowship in endocrinology, diabetes and metabolism at UT Southwestern Medical Center in Dallas.
As of April 2019, Dr. Leffert reported the following external relationships:
Funding for clinical trial expenses and staff, paid to North Texas Endocrine Center, from the following companies:
- AbbVie, for a study of atrasentan on type 2 diabetes with nephropathy.
- Novo Nordisk, for multiple type 1 and type 2 diabetes trials with new insulin analogs.
- Sanofi, for multiple trials involving type 2 diabetes with insulin glargine injections and type 1 or type 2 diabetes with hypercholesterolemia.
Dr. Leffert serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Association of Clinical Endocrinologists, Chancellor, receiving reimbursement for travel expenses.
- American Medical Association, Delegate, receiving reimbursement for travel expenses.
Alyson K. Myers, MD
Dr. Myers is a Clinical Educator and the Medical Director of Inpatient Diabetes at North Shore University Hospital in Manhasset, New York. She is also an Assistant Professor at the David and Barbara Zucker School of Medicine at Hofstra/Northwell. She is board certified in both Internal Medicine and Endocrinology, Diabetes and Metabolism. From 2015-2017, Dr. Myers was accepted as an Empire Clinical Research Investigators Program fellow.
Dr. Myers is a member of the American Board of Internal Medicine Endocrinology, Diabetes and Metabolism Board. She is an active member of the Endocrine Society as an abstract reviewer, former member of the Clinical Affairs Core Committee, CME course reviewer and a three-time presenter for the Early Career Forum. In 2019 she was honored as Top Doctor by Professional Organization of Women of Excellence Recognized (Power) and awarded the Salzman Award in Quality.
Dr. Myers attended the University of Virginia where she majored in French and minored in chemistry. She attended State University of New York Downstate for medical school, where she was the four-year recipient of the President's Award Scholarship. She completed a five-year combined internal medicine/psychiatry residency at Rush University Medical Center in Chicago, Illinois. During her fourth year, she served as chief resident. In 2012, she completed an endocrinology fellowship at the University of Texas Southwestern. During fellowship, she received a T32 training grant in the area of mood disorders under the mentorship of Dr. Madhukar Trivedi.
As of April 2021, Dr. Myers reported the following external relationships:
Grant funding from non-profit healthcare-related organizations for salary support, paid to North Shore University Hospital, from the following organizations:
- Patient-Centered Outcomes Research Institute, for serving as a co-Principal Investigator.
Christine Twining, MD
Dr. Twining is a board-certified endocrinologist and Medical Director at the Maine Medical Partners Center for Endocrinology and Diabetes, a group of eight endocrinologists in Scarborough, Maine. She practices general endocrinology with a focus on thyroid disease, metabolic bone disease and transitional care. Additionally, Dr. Twining is an Assistant Professor of Medicine at Tufts School of Medicine and enjoys teaching Tufts medical students and residents at Maine Medical Center, where she also serves as an advisor to internal medicine-pediatrics residents.
She has been a member of the board of directors for the American Association of Clinical Endocrinologists (AACE) since 2015. She served as AACE's representative to the Young Physicians Section of the AMA from 2010-2015 and served as the Fellow-in-Training Representative to the Board of Directors in 2007-2008. Dr. Twining served on the board of the New England Chapter of AACE and was its president in 2013-2014. She has served on many AACE committees, including Endocrine Training Support, Socioeconomics, Chapters, Membership, Pediatric Endocrinology, and Endocrine University and the Task Force on Women in Endocrinology, among others. Currently, she is a member of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism Board.
Dr. Twining has an artium baccalaureus degree from Harvard College and graduated from Duke University School of Medicine. She completed a combined internal medicine-pediatrics residency at Yale followed by an endocrinology fellowship at the University of South Carolina.
As of August 2020, Dr. Twining reported the following external relationships:
Dr. Twining serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- American Association of Clinical Endocrinologists, Board Member, without compensation.